Absci Corporation, a clinical-stage biopharmaceutical company utilizing generative AI, is set to participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. They will host a fireside chat on Monday, September 8, 2025, at 3:20 p.m. Eastern Time.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Absci Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9514464-en) on August 20, 2025, and is solely responsible for the information contained therein.